Shivalik Rasayan Limited reported a return to profitability in its first quarter of FY27, posting a consolidated net profit after tax of ₹14.97 crore for the quarter ended June 30, 2026. This stands in contrast to the net loss of ₹2.84 crore recorded in the corresponding quarter of the previous fiscal year.

The company’s total income from operations grew by 18.3% year-on-year to ₹227.61 crore, up from ₹192.44 crore in Q1FY26. The improvement in the top line contributed to a significant turnaround in the bottom line, with earnings per share (basic and diluted) rising to ₹5.39 from ₹1.34 in the prior year period.

What the Numbers Show

The divergence between standalone and consolidated results highlights the impact of subsidiaries on the group’s overall performance. While the standalone entity recorded a modest profit before tax of ₹0.91 crore against ₹4.49 crore in the previous year, the consolidated structure delivered a pre-tax profit (before exceptional items) of ₹16.58 crore. This suggests that the primary driver of the quarterly recovery lies within the consolidated operations rather than the parent company’s direct activities.

Financial Highlights

The Board of Directors approved the unaudited financial results on August 14, 2026. The results were filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Former Director Sanjay Bansal sold 50,000 equity shares of Shivalik Rasayan Limited for ₹1,24,87,360 on August 3, 2026, marking a significant reduction in his personal stake in the chemical manufacturer. The sale, executed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), reduced Bansal’s holding from 1,00,000 shares (0.63% of total equity) to 50,000 shares (0.32%). This divestment represents half of his previously disclosed holdings, signaling a continued exit from the company's equity.

The disclosure was submitted to the exchanges on August 5, 2026, under Regulation 7(3) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. As a connected person identified by the company, Bansal’s trading activities are subject to strict monitoring and disclosure requirements to prevent insider trading violations. The filing confirms that no derivatives trading was reported by Bansal during this period, and the transaction was conducted entirely on the open market.

Transaction Details

Regulatory Compliance

The intimation was filed in Form-D pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. Parul Arora, Company Secretary and Compliance Officer of Shivalik Rasayan Limited, digitally signed the disclosure on August 5, 2026. The company requested the exchanges to treat this intimation as compliance with the regulatory framework and record the same. The value of the transaction excludes taxes, brokerage, and other associated charges, as per standard reporting norms.